The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Replimune Group, Inc. (NASDAQ: REPL) or certain of its executive officers violated state or federal ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Replimune (REPL) shares plunged ~28% in the premarket on Tuesday after the FDA released a briefing document ahead of an advisory committee meeting scheduled to discuss the marketing application for ...
We may earn commission from links on this page, but we only recommend products we love. Promise. Whether you see the invisible string theory as a comforting metaphor, a spiritual belief, or just a fun ...
Replimune Group faces a pivotal FDA decision for RP1 in advanced melanoma, with a Sell rating reflecting approval odds and the current price. RP1 demonstrates real antitumor activity and durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results